NCT02957721View on ClinicalTrials.gov

Diabetes Engagement and Activation Platform

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

November 5, 2018

Study Completion Date

November 5, 2018

Conditions
Type 2 Diabetes (T2D)
Interventions
OTHER

Usual Care

Patients will not be given the intervention but receive usual care for T2D.

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT02957721 - Diabetes Engagement and Activation Platform | Biotech Hunter | Biotech Hunter